| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nabriva Therapeutics plc | Director | Ordinary Shares | 10.4K | $15.6K | $1.50 | Aug 2, 2022 | Direct |
| Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 67K | May 23, 2024 | Direct | ||
| Cidara Therapeutics, Inc. | Director | Stock Option (right to buy) | 2.13K | Jul 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics, Inc. | Jul 18, 2024 | 1 | $0 | 4 | Jul 19, 2024 | Director |
| ABUS | Arbutus Biopharma Corp | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| CDTX | Cidara Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| ABUS | Arbutus Biopharma Corp | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| NBRV | Nabriva Therapeutics plc | Aug 2, 2022 | 1 | -$2.16K | 4 | Aug 4, 2022 | Director |
| CDTX | Cidara Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| ABUS | Arbutus Biopharma Corp | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| NBRV | Nabriva Therapeutics plc | Aug 2, 2021 | 1 | -$1.35K | 4 | Aug 4, 2021 | Director |
| NBRV | Nabriva Therapeutics plc | Jul 28, 2021 | 2 | $0 | 4 | Jul 30, 2021 | Director |
| CDTX | Cidara Therapeutics, Inc. | Jun 23, 2021 | 1 | $0 | 4 | Jun 24, 2021 | Director |
| ABUS | Arbutus Biopharma Corp | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |